Liquid Biopsies and Non-Invasive Diagnostic Tools

Liquid biopsies represent a transformational shift in cancer diagnostics, offering a non-invasive way to detect tumors, monitor treatment response, and identify recurrence. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes in blood or other bodily fluids, clinicians can gain valuable insights into tumor genetics without requiring surgical tissue biopsies. These tools enable earlier detection, more frequent monitoring, and real-time evaluation of how tumors evolve under therapy. Liquid biopsies also support precision oncology by identifying actionable mutations that guide targeted treatments.

    Related Conference of Liquid Biopsies and Non-Invasive Diagnostic Tools

    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA

    Liquid Biopsies and Non-Invasive Diagnostic Tools Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in